Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.
Nura Bio has raised $73.8M in total funding. The most recent round was Series B. The last funding was announced in June 2026.
Nura Bio's investors include Samsara BioCapital, The Column Group, Sanofi Ventures, Euclidean Capital.
Nura Bio is headquartered in South San Francisco, United States.
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.
Nura Bio is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nura Bio — Funding & Investors." VCBacked, June 22, 2026, https://www.vcbacked.co/company/nura-bio. Accessed September 29, 2026.
VCBacked. (2026). Nura Bio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/nura-bio
{{cite web |title=Nura Bio — Funding & Investors |url=https://www.vcbacked.co/company/nura-bio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated